April 19, 2025
Operating Assets

Data Storage Corporation Reports 2024 Fiscal Year Financial Results and Provides Business Update

MELVILLE, N.Y., March 31, 2025 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a leading provider of multi-cloud hosting, managed cloud services, disaster recovery, cybersecurity, and IT automation, with direct connection to AWS, Microsoft Azure, and Google Cloud, today provided a business update and reported financial results for the year ended

Read More
Intangible Assets

Patent Index 2024: Japan ranks 3rd in European patent applications

European Patent Office received nearly 200 000 patent applications last year, with Japanese companies and inventors filing 10.6% of the total Electrical machinery/energy, transport and computers are leading technology fields for Japanese inventions Tokyo 1st in global city ranking Sony Group is among the EPO’s Top 10 applicant companies Four Japanese companies among the EPO’s

Read More
Financial Assets

2024 Full Year Financial Results

Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company“) 2024 Full Year Financial Results 2024 – a pivotal year marking the transition from developer to producer at our flagship Nalunaq mine TORONTO, ONTARIO – 28 March 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an independent mining company with a substantial

Read More
Operating Assets

Acutus Medical Reports Full Year 2024 Financial Results

CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024. Recent Highlights: 2024 Revenue from Continuing Operations of $20.2 million grew 181% year-over-year, from $7.2 million last year. Operating loss for continuing operations was $0.1 million, compared to 11.7

Read More
Intangible Assets

Patent applications from China at record level

European Patent Office received nearly 200 000 patent applications last year, with 10.1% coming from China China ranks 4th globally in European patent applications Huawei is No.2 among top applicant companies China recorded a 0.5% YoY increase in applications Strongest growth globally came from electrical machinery, apparatus, energy inventions Surge in AI and battery technology

Read More
Operating Assets

GameStop Reports Fourth Quarter and Fiscal Year 2024 Results

GRAPEVINE, Texas, March 25, 2025 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today released financial results for the fourth quarter and fiscal year ended February 1, 2025. The Company’s consolidated financial statements, including GAAP and non-GAAP results, are below. The Company’s Form 10-K and supplemental information can be found at https://investor.gamestop.com. FOURTH

Read More
Intangible Assets

With 66 patents filed in 2024, GTT confirms the acceleration of its innovation momentum and its technological leadership in the INPI ranking

With 66 patents filed in 2024, GTT confirms the acceleration of its innovation momentum and its technological leadership in the INPI ranking Paris, March 24, 2025 – The GTT Group, technological expert in membrane containment systems used to transport and store liquefied gases, announces the filing of a total of 66 patent applications with the

Read More
Operating Assets

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25 First patient enrolled in Phase 2 FALCON trial of TERN-601 for obesity with 12-week data expected 4Q25 Cash, cash equivalents and marketable securities of $358 million, expected to

Read More
Operating Assets

Touax: RESULTS 2024 Growth in turnover and operating profitability

PRESS RELEASE        Paris, 20 March 2025 – 5:45 pm YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION RESULTS 2024 Growth in turnover and operating profitability Turnover1 of €165.0m, up +€7.9m Increase of the operating EBITDA2 to €59.0m (+€3.6m) Group share of net profit: €3.9m (+€0.3m) Book value per share: €11.63 (+6%) Dividend increase to €0.15 per share

Read More
Operating Assets

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Hemophilia A presentation at American Society of Hematology (ASH) 66th Annual Meeting demonstrated sustained Factor VIII (FVIII) activity in nonhuman primate (NHP) study for more than 16 months Leveraged hemophilia A albumin platform to achieve in vivo proof-of-concept in multiple secreted protein deficiencies to support wholly-owned follow-on program Progressed four Wave 1 Ionis targets to

Read More